Depas (Etizolam)


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 39.7%
Ill-defined Disorder 13.6%
Depression 10.6%
Insomnia 6.5%
Hypertension 4.5%
Drug Exposure During Pregnancy 4.0%
Drug Use For Unknown Indication 3.5%
Parkinson's Disease 2.0%
Constipation 1.5%
Gastric Ulcer 1.5%
Gastrointestinal Disorder 1.5%
Hepatic Cirrhosis 1.5%
Infection 1.5%
Pyrexia 1.5%
Sleep Disorder 1.5%
Colitis Ulcerative 1.0%
Dementia Alzheimer's Type 1.0%
Hepatitis C 1.0%
Hypercholesterolaemia 1.0%
Irritability 1.0%
Suicide Attempt 15.0%
Somnolence 10.0%
White Blood Cell Count Increased 10.0%
Hepatic Function Abnormal 7.5%
Rhabdomyolysis 7.5%
Treatment Noncompliance 7.5%
Cerebral Infarction 5.0%
Tonsillitis 5.0%
White Blood Cell Count Decreased 5.0%
Amnesia 2.5%
Blood Potassium Increased 2.5%
Completed Suicide 2.5%
Compulsive Shopping 2.5%
Confusional State 2.5%
Constipation 2.5%
Drug Effect Decreased 2.5%
Drug Exposure During Pregnancy 2.5%
Drug Rash With Eosinophilia And Systemic Symptoms 2.5%
Fall 2.5%
Jaundice 2.5%
Concomitant
Multiple Myeloma 17.4%
Lung Adenocarcinoma 15.2%
Lupus Nephritis 8.4%
Drug Use For Unknown Indication 7.4%
Osteoporosis 6.5%
Diabetes Mellitus 5.8%
Cerebral Infarction 5.2%
Rheumatoid Arthritis 5.2%
Cardiac Failure 4.2%
Dementia Alzheimer's Type 3.2%
Hypertension 3.2%
Depression 2.9%
Hyperphosphataemia 2.6%
Staphylococcal Infection 2.3%
Arteriosclerosis Obliterans 1.9%
Cancer Pain 1.9%
Schizophrenia 1.9%
Breast Cancer 1.6%
Fluid Retention 1.6%
Non-small Cell Lung Cancer 1.6%
White Blood Cell Count Decreased 13.6%
Rash 11.0%
Pyrexia 9.3%
Interstitial Lung Disease 5.9%
Tremor 5.9%
Vomiting 5.9%
White Blood Cell Count Increased 5.1%
Hyperkalaemia 4.2%
Platelet Count Decreased 4.2%
Respiratory Failure 4.2%
Somnolence 4.2%
Liver Disorder 3.4%
Sudden Death 3.4%
Urinary Retention 3.4%
Urinary Tract Infection 3.4%
Erythema Multiforme 2.5%
Hepatic Function Abnormal 2.5%
Hypoglycaemia 2.5%
Oedema Peripheral 2.5%
Pneumonia Aspiration 2.5%

Drug Data